Some Possibilities to Study New Prophylactics against Nerve Agents
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Nerve agents belong to the most dangerous chemical warfare agents and can be/were misused by terrorists. Effective prophylaxis and treatment is necessary to diminish their effect. General principles of prophylaxis are summarized (protection against acetylcholinesterase inhibition, detoxification, treatment "in advance" and use of different drugs). They are based on the knowledge of mechanism of action of nerve agents. Among different examinations, it is necessary to test prophylactic effectivity in vivo and compare the results with protection in vitro. Chemical and biological approaches to the development of new prophylactics would be applied simultaneously during this research. Though the number of possible prophylactics is relatively high, the only four drugs were introduced into military medical practice. At present, pyridostigmine seems to be common prophylactic antidote; prophylactics panpal (tablets with pyridostigmine, trihexyphenidyl and benactyzine), transant (transdermal patch containing HI-6) are other means introduced into different armies as prophylactics. Scavenger commercionally available is Protexia®. Future development will be focused on scavengers, and on other drugs either reversible cholinesterase inhibitors (e.g., huperzine A, gallantamine, physostigmine, acridine derivatives) or other compounds.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Mini reviews in medicinal chemistry - 19(2019), 12 vom: 27., Seite 970-979 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bajgar, J [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antidotes |
---|
Anmerkungen: |
Date Completed 22.08.2019 Date Revised 22.08.2019 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1389557519666190301112530 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM294515224 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM294515224 | ||
003 | DE-627 | ||
005 | 20231225081640.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1389557519666190301112530 |2 doi | |
028 | 5 | 2 | |a pubmed24n0981.xml |
035 | |a (DE-627)NLM294515224 | ||
035 | |a (NLM)30827238 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bajgar, J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Some Possibilities to Study New Prophylactics against Nerve Agents |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.08.2019 | ||
500 | |a Date Revised 22.08.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Nerve agents belong to the most dangerous chemical warfare agents and can be/were misused by terrorists. Effective prophylaxis and treatment is necessary to diminish their effect. General principles of prophylaxis are summarized (protection against acetylcholinesterase inhibition, detoxification, treatment "in advance" and use of different drugs). They are based on the knowledge of mechanism of action of nerve agents. Among different examinations, it is necessary to test prophylactic effectivity in vivo and compare the results with protection in vitro. Chemical and biological approaches to the development of new prophylactics would be applied simultaneously during this research. Though the number of possible prophylactics is relatively high, the only four drugs were introduced into military medical practice. At present, pyridostigmine seems to be common prophylactic antidote; prophylactics panpal (tablets with pyridostigmine, trihexyphenidyl and benactyzine), transant (transdermal patch containing HI-6) are other means introduced into different armies as prophylactics. Scavenger commercionally available is Protexia®. Future development will be focused on scavengers, and on other drugs either reversible cholinesterase inhibitors (e.g., huperzine A, gallantamine, physostigmine, acridine derivatives) or other compounds | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Nerve agents | |
650 | 4 | |a antidotes | |
650 | 4 | |a cholinesterases | |
650 | 4 | |a in vitro | |
650 | 4 | |a in vivo | |
650 | 4 | |a prophylaxis | |
650 | 4 | |a scavengers. | |
650 | 7 | |a Cholinesterase Reactivators |2 NLM | |
650 | 7 | |a Nerve Agents |2 NLM | |
650 | 7 | |a Cholinesterases |2 NLM | |
650 | 7 | |a EC 3.1.1.8 |2 NLM | |
700 | 1 | |a Kassa, J |e verfasserin |4 aut | |
700 | 1 | |a Kucera, T |e verfasserin |4 aut | |
700 | 1 | |a Musilek, K |e verfasserin |4 aut | |
700 | 1 | |a Jun, D |e verfasserin |4 aut | |
700 | 1 | |a Kuca, K |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Mini reviews in medicinal chemistry |d 2001 |g 19(2019), 12 vom: 27., Seite 970-979 |w (DE-627)NLM121595404 |x 1875-5607 |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2019 |g number:12 |g day:27 |g pages:970-979 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389557519666190301112530 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 19 |j 2019 |e 12 |b 27 |h 970-979 |